A Randomized Phase II Study Of Imetelstat (GRN163L) In Combination With Paclitaxel (With Or Without Bevacizumab) in Patients With Locally Recurrent Or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2017
At a glance
- Drugs Imetelstat (Primary) ; Bevacizumab; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Apr 2011 Recruitment into the trial is progressing ahead of schedule according to a Geron Corporation media release.
- 10 Mar 2011 Additional lead trial investigator (Kathy Miller, MD) identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History